Single-Cell Multiomics Market to Reach $18.20 Billion by 2035 as AI and Genomics Lift Demand
Updated
Updated · GlobeNewswire · Aug 3
Single-Cell Multiomics Market to Reach $18.20 Billion by 2035 as AI and Genomics Lift Demand
1 articles · Updated · GlobeNewswire · Aug 3
Summary
The market is projected to grow from $2.99 billion in 2025 to $18.20 billion by 2035, implying a 19.81% CAGR as drug discovery, biomarker work and precision medicine adopt higher-resolution cellular analysis.
North America held a 41.85% revenue share in 2025, with the U.S. market seen rising from $0.98 billion to about $5.08 billion by 2035, while Asia Pacific is forecast to expand the fastest.
Single-cell genomics led products with a 34.20% share in 2025, but proteomics is expected to grow fastest at a 23.16% CAGR as researchers widen multiomics use cases.
Oncology accounted for 38.90% of applications and pharmaceutical and biotechnology companies for 39.10% of end users in 2025, underscoring cancer research and commercial R&D as the market's main demand base.
Droplet-based microfluidics dominated technology platforms with a 56.30% share, while spatial-omics platforms are forecast to post the fastest growth at a 24.50% CAGR, reflecting rising demand for tissue-level resolution.